Latest & greatest articles for prostate cancer screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on prostate cancer screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on prostate cancer screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for prostate cancer screening

101. Screening for prostate cancer: a decision analytic view

Screening for prostate cancer: a decision analytic view Screening for prostate cancer: a decision analytic view Screening for prostate cancer: a decision analytic view Krahn M D, Mahoney J E, Eckman M H, Trachtenberg J, Pauker S G, Detsky A S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. Health technology Screening for prostate cancer with prostate-specific antigen (PSA), transrectal ultrasound (TRUS) and digital rectal examination (DRE). Type of intervention Screening/secondary prevention. Economic study type Cost-utility analysis. Study population Cohorts of men between the ages of 50 and 70. Setting Medical centre. The economic study was carried out in Ontario (Canada). Dates to which data relate Dates for effectiveness and resource

1994 NHS Economic Evaluation Database.

102. A cost-effectiveness analysis of screening for carcinoma of the prostate by digital examination

A cost-effectiveness analysis of screening for carcinoma of the prostate by digital examination A cost-effectiveness analysis of screening for carcinoma of the prostate by digital examination A cost-effectiveness analysis of screening for carcinoma of the prostate by digital examination Love R R, Fryback D G, Kimbrough S R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening for stage-B prostate cancer. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Men, aged 60 years and over. Setting The study was carried out in the USA. Dates to which data relate Price related to 1984. Source of effectiveness data Review of studies. Modelling Epidemiological cohort model (model

1985 NHS Economic Evaluation Database.